Organization
Novartis Turkey, Istanbul, Turkey
1 abstract
Abstract
AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHÇET’S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENTOrg: Istanbul Faculty of Medicine, Istanbul, Turkey, Novartis Turkey, Istanbul, Turkey,